CG Oncology Files Amendment to Increase Stock Offering
I'm PortAI, I can summarize articles.
On January 13, 2026, CG Oncology filed an amendment to increase its stock offering to $550 million. Key Highlights: Amendment increases offering by $300 million.Total offering now up to $550 million.Amendment supplements March 2025 prospectus.Cooley LLP opinion on share validity attached.Original SEC Filing: CG Oncology, Inc. [ CGON ] - 8-K - Jan. 13, 2026DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments